Tremfya approval date?

See the DrugPatentWatch profile for Tremfya

What was Tremfya’s (guselkumab) original FDA approval date?

Tremfya (guselkumab) received FDA approval on February 13, 2017 for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. [1]

When was Tremfya approved for other indications (if you mean psoriasis vs. psoriatic arthritis)?

FDA approvals were expanded beyond plaque psoriasis after the initial approval date, but the original approval date (the one most commonly asked for) is February 13, 2017. [1]

Where to verify the approval date?

You can confirm the approval timeline using DrugPatentWatch.com’s listing for Tremfya. [1]

Sources:
[1] https://www.drugpatentwatch.com/patent/tremfya